Publications

Multiple academic articles reporting on the results of VAC4EU studies have been published in Vaccine, Drug Safety, and other journals. All VAC4EU publications are open access, with links to full text PDFs available below.

    Publications

Riefolo, F., et al. Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. Elsevier. 13 Nov 2023.
Ahmadizar F, et al. Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials. Drug Safety. 1 June 2023.
Raethke M, et al. Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose. Drug Safety. 7 Apr 2023.
Willame C, et al. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study. Vaccine. 1 Apr 2023.
Bots SH, et al. Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. Frontier Pharmacology. 24 Nov 2022.
Emborg HD, et al. ADVANCE system testing: can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: an example. Vaccine. 22 Dec 2022.
Weibel D, et al. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination. Vaccine. 22 Dec 2020.
Bollaerts K, et al. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.. Vaccine. 22 Dec 2020.